	Zysk Brutto Na Sprzedaży		Data
Acadia Pharmaceuticals	USD 257.76M	778K	2025-12
Adma Biologics	USD 75.63M	8.4M	2025-09
ALKERMES	USD 338.34M	72.51M	2025-12
AstraZeneca	USD 12.39B	5M	2025-12
BioCryst Pharmaceuticals	USD -88.88M	202.74M	2024-12
Bristol-Myers Squibb	USD 8.79B	110M	2025-09
Cipla	INR 41.64B	6.31B	2025-12
Clal Biotechnology	ILS -857K	1.42M	2022-06
Compugen	USD 241K	649K	2025-09
CSL	USD 4.46B	2.71B	2025-12
Eli Lilly	USD 14.59B	1.48B	2025-09
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
GlaxoSmithKline	GBP 6.18B	106M	2025-12
Grifols	EUR 766.49M	39.74M	2024-12
Halozyme Therapeutics	USD 281.77M	2.41M	2025-09
Ionis Pharmaceuticals	USD 195M	40M	2025-12
J&J	USD 16.6B	118M	2025-12
Merck	USD 13.42B	431M	2025-09
Minerva Neurosciences	-4.27M	26.79M	2024-12
Neurocrine Biosciences	USD 787.9M	7M	2025-12
Novartis	USD 10.82B	695M	2025-09
Novavax	USD 23.89M	239.21M	2024-09
Pfizer	USD 3.54B	7.61B	2025-09
Roche Holding	CHF 22.09B	10.04B	2025-12
Sanofi	EUR 8.45B	1.31B	2025-12
Takeda	JPY 790.55B	262.97B	2025-12
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12

Minerva Neurosciences Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.